Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Eastnine | EAST | May 31, 2024 | 42.00 | +0.24 |
EasyFill B | EASYB | May 31, 2024 | 0.27 | +10.74 |
EatGood | EATG | May 31, 2024 | 0.92 | -7.60 |
eBlitz Group | EBLITZ | May 31, 2024 | 0.65 | 0.00 |
Ecoclime Group B | ECCB | May 31, 2024 | 2.58 | +2.38 |
ECOMB | ECOM | May 31, 2024 | 0.13 | -11.03 |
EcoRub B | ECOB | May 31, 2024 | 0.12 | -11.44 |
Ectin Research | ECTINB | May 31, 2024 | 0.84 | +26.12 |
Edyoutec AB | EDYOU | May 31, 2024 | 0.62 | +14.84 |
eEducation Albert | ALBERT | May 31, 2024 | 3.70 | -4.39 |
Eevia Health | EEVIA | May 31, 2024 | 0.57 | -0.70 |
Effnetplattformen Holding | EFFH | May 31, 2024 | 4.60 | +4.55 |
Egetis Therapeutics | EGTX | May 31, 2024 | 8.08 | -7.23 |
Ekobot | EKOBOT | May 31, 2024 | 0.15 | -0.66 |
Elanders B | ELANB | May 31, 2024 | 106.00 | +0.76 |
Electrolux A | ELUXA | May 31, 2024 | 117.00 | 0.00 |
Electrolux B | ELUXB | May 31, 2024 | 99.78 | +1.63 |
Electrolux Professional B | EPROB | May 31, 2024 | 69.30 | +1.76 |
Elekta B | EKTAB | May 31, 2024 | 86.15 | -0.17 |
Elicera Therapeutics | ELIC | May 31, 2024 | 0.97 | +3.40 |
Ellen | ELN | May 31, 2024 | 1.38 | +0.73 |
Ellwee | ELLWEE | May 31, 2024 | 5.14 | -0.77 |
Elmera Group | ELMRAO | May 31, 2024 | 31.05 | 0.00 |
Elon AB (publ) | ELON | May 31, 2024 | 28.00 | +3.32 |
Eltel | ELTEL | May 31, 2024 | 6.66 | +0.91 |
EmbeddedArt Group AB (publ) | EMART | May 31, 2024 | 11.20 | -4.27 |
Embellence Group | EMBELL | May 31, 2024 | 31.00 | 0.00 |
Embracer Group B | EMBRACB | May 31, 2024 | 26.18 | -1.65 |
Emilshus | EMILPREF | May 31, 2024 | 30.00 | 0.00 |
Emilshus B | EMILB | May 31, 2024 | 37.00 | +5.71 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.